[HTML][HTML] Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome-where do we go from here?

A Dushianthan, R Cusack, V Goss, AD Postle… - Critical Care, 2012 - Springer
Acute lung injury and acute respiratory distress syndrome (ARDS) are characterised by
severe hypoxemic respiratory failure and poor lung compliance. Despite advances in clinical …

[引用][C] Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome-where do we go from here?

A Dushianthan, R Cusack, V Goss, AD Postle… - Critical Care, 2012 - cir.nii.ac.jp
Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress
syndrome - where do we go from here? | CiNii Research CiNii 国立情報学研究所 学術情報 …

[PDF][PDF] Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome–where do we go from here?

A Dushianthan, R Cusack, V Goss, AD Postle… - academia.edu
Acute lung injury and acute respiratory distress syndrome (ARDS) are characterised by
severe hypoxemic respiratory failure and poor lung compliance. Despite advances in clinical …

Clinical review: exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome-where do we go from here?

A Dushianthan, R Cusack, V Goss, AD Postle… - Critical …, 2012 - eprints.soton.ac.uk
Acute lung injury and acute respiratory distress syndrome (ARDS) are characterised by
severe hypoxemic respiratory failure and poor lung compliance. Despite advances in clinical …

Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome--where do we go from here?

A Dushianthan, R Cusack, V Goss… - Critical care …, 2012 - pubmed.ncbi.nlm.nih.gov
Acute lung injury and acute respiratory distress syndrome (ARDS) are characterised by
severe hypoxemic respiratory failure and poor lung compliance. Despite advances in clinical …

[HTML][HTML] Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome-where do we go from here?

A Dushianthan, R Cusack, V Goss… - Critical …, 2012 - ccforum.biomedcentral.com
Acute lung injury and acute respiratory distress syndrome (ARDS) are characterised by
severe hypoxemic respiratory failure and poor lung compliance. Despite advances in clinical …

[HTML][HTML] Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome-where do we go from here?

A Dushianthan, R Cusack, V Goss, AD Postle… - Critical Care, 2012 - ncbi.nlm.nih.gov
Acute lung injury and acute respiratory distress syndrome (ARDS) are characterised by
severe hypoxemic respiratory failure and poor lung compliance. Despite advances in clinical …

Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome--where do we go from here?

A Dushianthan, R Cusack, V Goss… - Critical Care (London …, 2012 - europepmc.org
Acute lung injury and acute respiratory distress syndrome (ARDS) are characterised by
severe hypoxemic respiratory failure and poor lung compliance. Despite advances in clinical …

[PDF][PDF] Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome–where do we go from here?

A Dushianthan, R Cusack, V Goss, AD Postle… - scienceopen.com
Acute lung injury and acute respiratory distress syndrome (ARDS) are characterised by
severe hypoxemic respiratory failure and poor lung compliance. Despite advances in clinical …

[PDF][PDF] Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndromeá–where do we go from here?

A Dushianthan, R Cusack, V Goss, AD Postle… - researchgate.net
Acute lung injury and acute respiratory distress syndrome (ARDS) are characterised by
severe hypoxemic respiratory failure and poor lung compliance. Despite advances in clinical …